The blind leading the blind: use and misuse of blinding in randomized controlled trials.
暂无分享,去创建一个
[1] P. Gøtzsche,et al. Blinding during data analysis and writing of manuscripts. , 1996, Controlled clinical trials.
[2] D. Moher,et al. Turning a blind eye:Testing the success of blinding and the CONSORT statement , 2004, BMJ : British Medical Journal.
[3] G. Guyatt,et al. Physician interpretations and textbook definitions of blinding terminology in randomized controlled trials. , 2001, JAMA.
[4] David L Sackett,et al. Commentary: Measuring the success of blinding in RCTs: don't, must, can't or needn't? , 2007, International journal of epidemiology.
[5] Jafar Kolahi,et al. Towards a proposal for assessment of blinding success in clinical trials: up-to-date review. , 2009, Community dentistry and oral epidemiology.
[6] T. Kaptchuk,et al. Intentional Ignorance: A History of Blind Assessment and Placebo Controls in Medicine , 1998, Bulletin of the history of medicine.
[7] D. Moher,et al. CONSORT 2010 explanation and elaboration: updated guidelines for reporting parallel group randomised trials. , 2012, International journal of surgery.
[8] F. Miller,et al. Sham Surgery: An Ethical Analysis , 2003, The American journal of bioethics : AJOB.
[9] P. Bossuyt,et al. Empirical evidence of design-related bias in studies of diagnostic tests. , 1999, JAMA.
[10] S. Senn. Turning a blind eye: Authors have blinkered view of blinding , 2004, BMJ : British Medical Journal.
[11] D. McCallie,et al. Angina pectoris and the placebo effect. , 1979, The New England journal of medicine.
[12] Henneicke-von Zepelin Hh. Letter to the Editor [2] (multiple letters) , 2005 .
[13] D. Moher,et al. CONSORT 2010 statement: Updated guidelines for reporting parallel group randomised trials , 2010, Journal of pharmacology & pharmacotherapeutics.
[14] Duff Waring,et al. Turning a blind eye: the success of blinding reported in a random sample of randomised, placebo controlled trials , 2004, BMJ : British Medical Journal.
[15] J. Lonner,et al. The ethics of sham surgery in clinical orthopaedic research. , 2007, The Journal of bone and joint surgery. American volume.
[16] R. J. Hayes,et al. Empirical evidence of bias. Dimensions of methodological quality associated with estimates of treatment effects in controlled trials. , 1995, JAMA.
[17] G. Guyatt,et al. In the dark: the reporting of blinding status in randomized controlled trials. , 2002, Journal of clinical epidemiology.
[18] D. Sackett. Turning a blind eye:Why we don't test for blindness at the end of our trials , 2004, BMJ : British Medical Journal.
[19] Heejung Bang,et al. Assessment of blinding in clinical trials. , 2004, Controlled clinical trials.
[20] Harri Hemilä,et al. Assessment of blinding may be inappropriate after the trial. , 2005, Contemporary clinical trials.
[21] I. Chalmers,et al. The Landscape and Lexicon of Blinding in Randomized Trials , 2002, Annals of Internal Medicine.
[22] D. Moher,et al. CONSORT 2010 Statement: updated guidelines for reporting parallel group randomised trials , 2010, Journal of clinical epidemiology.
[23] D. Moher,et al. CONSORT 2010 Explanation and Elaboration: updated guidelines for reporting parallel group randomised trials , 2010, BMJ : British Medical Journal.
[24] T. Kaptchuk. The double-blind, randomized, placebo-controlled trial: gold standard or golden calf? , 2001, Journal of clinical epidemiology.
[25] A. Hrõbjartsson,et al. Blinded trials taken to the test: an analysis of randomized clinical trials that report tests for the success of blinding. , 2007, International journal of epidemiology.